11 Fizer Pharmaceutical paid $88 million on January 2 2018, for 8 million shares of Carne Cosmetics common stock. The investment represents a 30% Interest in the net assets of Care and gave Fizer the ability to exercise significant influence over Came's operations Fizer recelved dividends of $1 per share on December 21, 2018, and Carne reported net income of $60 million for the year ended December 31, 2018. The fair value of Carne's common stock at December 31, 2018, was $38.50 per share 2.5 The book value of Came's net assets was $230 million The fair value of Carne's depreciable assets exceeded their book value by $30 million. These assets had an average remaining useful life of nine years The remainder of the excess of the cost of the investment over the book value of net assets purchased was attributable to goodwill Required: Complete the table below and prepare the appropriate journal entries related to the investment during 2018, Bence Complete this question by entering your answers in the tabs below. Calculation General Journal Complete the table below. (Enter your answers in million, c. 10,000,000 should be entered as 10)) Investee (sin millions) Ownership Not Assets Net Assets Interest Difference Purchased Attributable to Purchase Price $ 00 Fair value Came's sets ol Book Value Came's assets 5 0 Years Depreciation adjustment Investment revenue Adjustment 5 General Journal > View transaction list Journal entry worksheet 2 3 5 > Record the investment in Carne Cosmetics shares. Note: Enter debits before credits. Event General Journal Debit Credit Record entry Clear entry View general journal